|
1
|
Balkissoon R, Lommatzsch S, Carolan B and
Make B: Chronic obstructive pulmonary disease: A concise review.
Med Clin North Am. 95:1125–1141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harjes U: Non-small cell lung cancer:
Where there's smoke. Nat Rev Cancer. 17:634–635. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Houghton AM: Mechanistic links between
COPD and lung cancer. Nat Rev Cancer. 13:233–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P,
Wangensteen KJ, Simithy J, Lan Y, Lin Y, Zhou Z, et al: Cytoplasmic
chromatin triggers inflammation in senescence and cancer. Nature.
550:402–406. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barabasi AL, Gulbahce N and Loscalzo J:
Network medicine: A network-based approach to human disease. Nat
Rev Genet. 12:56–68. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boelens MC, Gustafson AM, Postma DS, Kok
K, van der Vries G, van der Vlies P, Spira A, Lenburg ME, Geerlings
M, Sietsma H, et al: A chronic obstructive pulmonary disease
related signature in squamous cell lung cancer. Lung Cancer.
72:177–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan S and Li X, Tie L, Pan Y and Li X:
KIAA0101 is associated with human renal cell carcinoma
proliferation and migration induced by erythropoietin. Oncotarget.
7:13520–13537. 2016.PubMed/NCBI
|
|
9
|
Martin A, Ochagavia ME, Rabasa LC, Miranda
J, Fernandez-de-Cossio J and Bringas R: BisoGenet: A new tool for
gene network building, visualization and analysis. BMC
Bioinformatics. 11:912010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goswami CP and Nakshatri H: PROGgene: Gene
expression based survival analysis web application for multiple
cancers. J Clin Bioinforma. 3:222013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goswami CP and Nakshatri H: PROGgeneV2:
Enhancements on the existing database. BMC Cancer. 14:9702014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng Z, Yang D, Huang X and Xiao Z: Effect
of carbocisteine on patients with COPD: A systematic review and
meta-analysis. Int J Chron Obstruct Pulmon Dis. 12:2277–2283. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ho T, Cusack RP, Chaudhary N, Satia I and
Kurmi OP: Under- and over-diagnosis of COPD: A global perspective.
Breathe (Sheff). 15:24–35. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nielsen AO, Jensen CS, Arredouani MS, Dahl
R and Dahl M: Variants of the ADRB2 gene in COPD: Systematic review
and meta-analyses of disease risk and treatment response. COPD.
14:451–460. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao H, Wu X, Dong CL, Wang BY, Zhao J and
Cao XE: Association between ADRB2 genetic polymorphisms and the
risk of chronic obstructive pulmonary disease: A case-control study
in a chinese population. Genet Test Mol Biomarkers. 21:491–496.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hussein MH, Sobhy KE, Sabry IM, El Serafi
AT and Toraih EA: Beta2-adrenergic receptor gene
haplotypes and bronchodilator response in Egyptian patients with
chronic obstructive pulmonary disease. Adv Med Sci. 62:193–201.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agac D, Estrada L and Farrar D: Beta-2
adrenergic receptor signaling prevents hyperinflammation through
early release of IL-10. J Immunology. 198:221–224. 2017.
|
|
18
|
Pont-Kingdon G, Bohnsack J, Sumner K,
Whiting A, Clifford B, Guthery SS, Jorde LB, Lyon E and Prahalad S:
Lack of association between beta 2-adrenergic receptor
polymorphisms and juvenile idiopathic arthritis. Scand J Rheumatol.
38:91–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Braadland PR, Ramberg H, Grytli HH and
Tasken KA: β-Adrenergic receptor signaling in prostate cancer.
Front Oncol. 4:3752015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pérez-Sayáns M, Somoza-Martín JM,
Barros-Angueira F, Diz PG, Gándara Rey JM and García-García A:
Beta-adrenergic receptors in cancer: Therapeutic implications.
Oncol Res. 19:45–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Dormady SP and Basch RS:
Identification of four human cDNAs that are differentially
expressed by early hematopoietic progenitors. Exp Hematol.
28:1286–1296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Kalkum M, Chait BT and Roeder RG:
The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the
JNK pathway through the integral subunit GPS2. Mol Cell. 9:611–623.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma M and Yu N: Over-expression of TBL1XR1
indicates poor prognosis of serous epithelial ovarian cancer.
Tohoku J Exp Med. 241:239–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu F, He Y, Cao Q, Liu N and Zhang W:
TBL1XR1 is highly expressed in gastric cancer and predicts poor
prognosis. Dis Markers. 2016:24365182016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Scott DW, Mungall KL, Ben-Neriah S, Rogic
S, Morin RD, Slack GW, Tan KL, Chan FC, Lim RS, Connors JM, et al:
TBL1XR1/TP63: A novel recurrent gene fusion in B-cell non-Hodgkin
lymphoma. Blood. 119:4949–4952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Campregher PV, Halley ND, Vieira GA,
Fernandes JF, Velloso ED, Ali S, Mughal T, Miller V, Mangueira CL,
Odone V and Hamerschlak N: Identification of a novel fusion
TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring
the DEK-NUP214 fusion and clinical response to dasatinib. Leuk
Lymphoma. 58:2969–2972. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang S, Han H, Hu Y, Yang W, Lv Y, Wang L,
Zhang L and Ji J: MicroRNA-130a-3p suppresses cell migration and
invasion by inhibition of TBL1XR1-mediated EMT in human gastric
carcinoma. Mol Carcinog. 57:383–392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moiseenko A, Kheirollahi V, Chao CM,
Ahmadvand N, Quantius J, Wilhelm J, Herold S, Ahlbrecht K, Morty
RE, Rizvanov AA, et al: Origin and characterization of alpha smooth
muscle actin-positive cells during murine lung development. Stem
Cells. 35:1566–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zou YF, Xu JH, Gu YY, Pan FM, Tao JH, Wang
DG, Xu SQ, Xiao H, Chen PL, Liu S, et al: Single nucleotide
polymorphisms of HSP90AA1 gene influence response of SLE patients
to glucocorticoids treatment. Springerplus. 5:2222016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng Q, Chang JT, Geradts J, Neckers LM,
Haystead T, Spector NL and Lyerly HK: Amplification and high-level
expression of heat shock protein 90 marks aggressive phenotypes of
human epidermal growth factor receptor 2 negative breast cancer.
Breast Cancer Res. 14:R622012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui X, Xing J, Liu Y, Zhou Y, Luo X, Zhang
Z, Han W, Wu T and Chen W: COPD and levels of Hsp70 (HSPA1A) and
Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: A
case-control study. Cell Stress Chaperones. 20:473–481. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Diakos CI, Charles KA, McMillan DC and
Clarke SJ: Cancer-related inflammation and treatment effectiveness.
Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi SH, Nam JK, Kim BY, Jang J, Jin YB,
Lee HJ, Park S, Ji YH, Cho J and Lee YJ: HSPB1 inhibits the
endothelial-to-mesenchymal transition to suppress pulmonary
fibrosis and lung tumorigenesis. Cancer Res. 76:1019–1030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Desmedt C, Piette F, Loi S, Wang Y,
Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y,
d'Assignies MS, et al: Strong time dependence of the 76-gene
prognostic signature for node-negative breast cancer patients in
the TRANSBIG multicenter independent validation series. Clin Cancer
Res. 13:3207–3214. 2007. View Article : Google Scholar : PubMed/NCBI
|
